Cognition Therapeutics Inc. Made Headway

Wed, Nov 30, 2022 at 07:04 PM
Cognition Therapeutics Inc. Made Headway

Cognition Therapeutics Inc. (CGTX:NASDAQ) soared at $3.51, a gain of 41.5%. On Wed, Nov 30, 2022, CGTX:NASDAQ hit a New 2-Week High of $3.51. The stock got featured on our News Catalysts scanner on Mon, Nov 28, 2022 at 08:08 AM in the 'BIOTECH' category. From Wed, Nov 16, 2022, the stock recorded 77.78% Up Days and 60.00% Green Days

The stock spiked on Thu, Aug 04, 2022 at $6.27 with a volume of 21M+.

About Cognition Therapeutics Inc. (CGTX:NASDAQ)

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative...

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.